SkinBioTherapeutics PLC - Newcastle, England-based life science company focused on skin health - Raises £3.0 million through placing of 15.9 million shares at 19 pence each. Says placing was completed through an accelerated bookbuild and was ‘materially oversubscribed’. Placing price represents a 9.5% discount to SkinBio’s closing middle market price of 21p per share on November 15, the day before it launched the placing. Company says the placing shares will be admitted to AIM on Wednesday and will represent around 9.2% of its total issued share capital.

Current stock price: 20.50 pence, down 4.7% on Friday in London

12-month change: down 14%

Copyright 2023 Alliance News Ltd. All Rights Reserved.